Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Susceptible infections Age: Adult |
Dose: Intravenous – 15,000-25,000 U/kg daily Frequency: continuous intravenous drip or intermittent infusion every 12 hours at 60-120 minute duration Note: Maximum: 2,000,000 U/day |
|
Indication: Susceptible infections Age: Adult |
Dose: Intramuscular – 25,000-30,000 U/kg daily Frequency: in divided doses every 4-6 hours Note: Maximum: 2,000,000 U/day |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Susceptible infections Age: Adult |
Dose: Intravenous – 15,000-25,000 U/kg Frequency: daily Note: by continuous intravenous drip or intermittent infusion every 12 hours at 60-120 min duration. Maximum: 2,000,000 U/day |
|
Indication: Susceptible infections Age: less than 2 years |
Dose: Intravenous – 40,000 U/kg Frequency: daily in divided doses every 12 hours |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal Impairment with Creatinine Clearance greater than 20 mL/minute |
Dose: Usual dose – 75-100% usual dose/day Frequency: divided every 12 hours |
|
Condition: Renal Impairment with Creatinine Clearance 5-20 mL/minute |
Dose: Usual dose – 50% usual dose/day Frequency: divided every 12 hours |
Administration
- Can be given IV or IM
- For IV, infuse over 60-90 minutes
Side Effect
- Anaphylactoid reactions with dyspnea and tachycardia
- Eosinophilia
- Fever
- Nephrotoxicity
- Neurotoxicity
- Skin exanthemata
- Urticaria
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Bacitracin, streptomycin, neomycin, kanamycin, gentamicin, tobramycin, amikacin, cephaloridine, paromomycin, viomycin, colistin
|
Additive neurotoxic or nephrotoxic effect
|
|
Neuromuscular blockers (e.g. anesthetics, Muscle Relaxants (Baclofen, Cyclobenzaprine, Tizanidine, Dantrolene))
|
Increased risk of respiratory paralysis
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Nephrotoxic Drug Use
|
Increased kidney damage risk
|
|
Neurotoxic Drug Use
|
Risk of nerve damage
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Before reconstitution, do not store above 30°C; and keep away from light and out of the reach of children. After reconstitution or dilution, unused portion must be stored at 2° to 8°C and should be discarded after 72 hours if not used.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.